We’re Driven by a Bold Mission: To Revolutionize
Radiation Protection

Todd Flohr is the CEO and Co-Founder of Salus Scientific. Since its inception, Todd has led the company’s strategy, operations, and global growth. Under his leadership, Salus has transformed a napkin sketch into patented, market-ready med-tech innovations, secured multi-million-dollar funding, and launched international expansion. With a strong background in sales and leadership across the healthcare sector, Todd previously held key roles at HeartFlow, Vital Connect, and Abbott Vascular, consistently driving growth and earning top performance awards. He holds a B.A. in Corporate Communications with a Business minor from the College of Charleston.

Jon practices in the areas of pharmacy, drug, and medical device law. Following law school, he practiced at Nelson Mullins Riley & Scarborough LLP. His experience has also included issues related to the FDA, Board licensing and permitting, controlled substances, federal and state compliance pertaining to the purchase and sale of pharmaceuticals, Jon serves as General Counsel and on the Board of Directors for Salus Scientific Corp., is an Adjunct Clinical Professor, Department of Clinical Pharmacy and Outcome Sciences at the Medical University College of Pharmacy and has served in the same role at the University of South Carolina College of Pharmacy.

Keith is the President and CFO of Salus Scientific, bringing 20 years of experience in finance and investment management. Following the creation of his private equity fund, Harbor Hill Investments, Keith played a key role in launching the company’s primary financing, core G-Lift product, and general corporate structure and was the first non-founding investor in Salus. Prior to Salus, Keith was the Director of US Fundamental Trading for Surveyor Capital, a Division of Citadel LLC. Additionally, he spent over 15 years as a Director in Citigroup's Equity Division and a Partner at Level Global Investors, LP. Keith is on the board of LnQ Inc., and maintains various advisory roles for Harbor Hill portfolio companies. Keith graduated from Lafayette College with a dual degree in Economics and Government.

Dr. Moore is a board-certified orthopedic surgeon specializing in microvascular and complex upper extremity surgery. A graduate of UNC-Chapel Hill and UNC School of Medicine, he completed his residency and internship at the Hospital of the University of Pennsylvania, followed by a fellowship in hand and microvascular surgery at Duke University. Based in Wilmington, NC, Dr. Moore continues to practice while actively lecturing nationally and internationally.

Dr. Buchanan is the Founder of Salus Scientific and a practicing interventional cardiologist. After completing his cardiology training at Wake Forest in 1992, he founded Coastal Cardiology Associates in Wilmington, NC, which he grew to 15 cardiologists before its acquisition by New Hanover Regional Medical Center in 2008. He later founded Coastal Cardiovascular Associates, where he continues to treat patients and perform coronary interventions. Dr. Buchanan holds multiple patents and is passionate about solving critical problems that impact patient and provider safety.

Ron Sancho has 25 years of experience in cardiovascular sales. Starting in pharmaceuticals as a sales representative in 1993, Ron quickly moved from selling to representing his company’s product line -57 products – to residents and fellows in teaching institutions such as LSU and Tulane.

Turning his attention to cardiovascular disease, Ron helped build and sell two pharmaceutical companies, KOS and CVT, as a district and regional manager, respectively.

After 20 years in cardiovascular sales, Ron realized that physicians needed better technology to detect and image microvascular disease, especially in women, so that they could diagnose and treat their patients earlier and with greater success. Ron founded Cardio Health Solutions, LLC in 2013.

Dr. Majoria has been in private practice for 28 years at the largest hospital in Louisiana, Our Lady of the Lake Regional Medical Center, with 988 beds and multiple sister facilities. He is the Chief of IR and has been responsible for building the IR service into one of the premier IR practices in the country, performing multiple complex procedures, including a high volume of embolization cases and stroke thrombectomy. OLOL is a level 1 trauma center and a comprehensive stroke center. He takes full IR and diagnostic calls and prides himself on maximum efficiency and effectiveness in patient care. Ryan is the founder and CEO of LnQ Inc., a SaaS company that helped solve the workforce issues of manpower shortage and burnout, initially in radiology.

Ravi is a vascular surgeon at MUSC Health in Charleston, SC, whose clinical interests are primarily in treating aortic disease with advanced and minimally invasive techniques. He is an expert on using new technology, such as fenestrated stents, to manage aortic aneurysms and other aortic conditions. Dr. Veeraswamy performs both traditional surgery and minimally invasive stent techniques. He also performs other procedures such as carotid artery surgery and lower extremity bypass surgery for patients suffering from peripheral artery disease (PAD). Dr. Veeraswamy has done extensive research and has published widely on aortic diseases. Since joining MUSC in 2016, Dr. Veeraswamy has been the Chief of Vascular Surgery. Before joining MUSC, he was on faculty at Emory University for a decade. Dr Veeraswamy is a native of SC and graduated from Irmo High School in Columbia, SC. He graduated from the Johns Hopkins University School of Medicine and completed residency and fellowship training at Washington University School of Medicine. He is the former President of the Vascular & Endovascular Surgery Society (VESS).